Kusajili – Clinical trials directory

Result of your search per sponsor: Menarini IFR – International Division

Woman and Man Max 99 years
Menarini IFR – International Division Update Il y a 4 ans

Otilonium Bromide in Irritable Bowel Syndrome – (OBIS) Double blind, randomized, parallel group, placebo-controlled study to evaluate the effect of otilonium bromide on abdominal pain and quality of life in patients with irritable bowel syndrome Barostat sub-study: Effect of otilonium bromide versus placebo on the perception of rectal distension in patients with irritable bowel syndrome (IBS) Confirm efficacy of otilonium bromide for symptom control (frequency of abdominal pain in patients with irritable bowel syndrome (IBS) in a superiority trial versus placebo.

Country None
organs None
Specialty None

Closed trial

More information